NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Monday 14 April 2008

Codexis files for IPO

Codexis hope to raise around $100m in an IPO underwritten by Credit Suisse Securities, Goldman Sachs, Piper Jaffray, RBC Capital Markets and Thomas Weisel Partners. Codexis did not reveal the offer price or number of shares to be sold in its submission to the SEC. Last year Codexis had sales of $25.3m but made an overall loss of $39m. Since it was founded as a spin out from Maxygen, Codexis has accumulated a deficit of $94.2m.
Forbes

No comments: